Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%
Lithium
43.34
0.37%
Gold
2,660.40
0.2%
Copper
4.22
0.56%
Oil
68.29
(0.22%)
Bitcoin
98,113.22
1.08%
FTSE 100
8,349.40
0.16%
Nikkei 225
39,091.17
(0.71%)
Dow Jones
44,765.71
(0.61%)
Iron Ore
104.40
0.59%
USD/AUD
0.64
(0.42%)
Hang Seng
19,889.69
1.42%

INVEX Therapeutics Ltd

IXC

ASX

Invex Therapeutics Ltd (IXC) is a biopharmaceutical company with a specific focus on the development and commercialization of Exenatide as a treatment for neurological conditions associated with raised intracranial pressure. This pressure can be a serious issue in various neurological conditions, including idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. Invex is working to establish Exenatide, a drug already approved for other uses, as a new and effective treatment option in this area of high unmet medical need.

Latest Posts

Line Chart with Gradient
Price
$0.072
0 (0%)
At Close 05/12 (AEST)
Related Companies
ONCOSIL MEDICAL LTD
$OSL
CSL LIMITED
$CSL
ANAGENICS LIMITED
$AN1
AFT PHARMACEUTICALS LIMITED
$AFP
ECOFIBRE LIMITED
$EOF

Leave a Comment on IXC


Comments for IXC

    Latest Posts

    invex-therapeutics-asx-ixc-collaborates-with-tessara-therapeutics-for-new-research-ixc
    Health Care $IXC

    Invex Therapeutics (ASX: $IXC) collaborates with Tessara Therapeutics for new research

    Research collaboration to explore Exenatide's potential in preventing cell death in neurological conditions

    October 8, 2024
    invex-therapeutics-asx-ixc-restructures-operations-after-trial-closure-ixc
    Health Care $IXC

    Invex Therapeutics (ASX: $IXC) restructures operations after trial closure

    Challenges lead to restructuring and progress in new therapeutic areas

    August 26, 2024
    invex-therapeutics-asx-ixc-announces-ato-class-ruling-on-return-of-capital-ixc
    Health Care $IXC

    Invex Therapeutics (ASX: $IXC) announces ATO class ruling on return of capital

    ATO confirms no assessable dividend for shareholders from $0.14 per share return of capital

    March 20, 2024
    invex-therapeutics-asx-ixc-terminates-manufacturing-agreement-with-peptron-ixc
    Health Care $IXC

    invex therapeutics (ASX: $IXC) terminates manufacturing agreement with peptron

    Agreement termination includes waiver of regulatory fee and licensing of PresendinTM for IIH in Korea and China

    January 14, 2024
    invex-therapeutics-asxixc-terminates-manufacturing-agreement-with-peptron-ixc
    Health Care $IXC

    invex therapeutics (ASX:$IXC) terminates manufacturing agreement with peptron

    Agreement termination includes waiver of regulatory fee and licensing of PresendinTM for IIH in Korea and China

    December 26, 2023

    IXC

    $IXC

    Invex Therapeutics (ASX: $IXC) collaborates with Tessara Therapeutics for new research

    Research collaboration to explore Exenatide's potential in preventing cell death in neurological conditions

    IXC

    $IXC

    Invex Therapeutics (ASX: $IXC) restructures operations after trial closure

    Challenges lead to restructuring and progress in new therapeutic areas

    IXC

    $IXC

    Invex Therapeutics (ASX: $IXC) announces ATO class ruling on return of capital

    ATO confirms no assessable dividend for shareholders from $0.14 per share return of capital

    IXC

    $IXC

    invex therapeutics (ASX: $IXC) terminates manufacturing agreement with peptron

    Agreement termination includes waiver of regulatory fee and licensing of PresendinTM for IIH in Korea and China

    IXC

    $IXC

    invex therapeutics (ASX:$IXC) terminates manufacturing agreement with peptron

    Agreement termination includes waiver of regulatory fee and licensing of PresendinTM for IIH in Korea and China

    Related Companies
    OPTHEA LIMITED
    $OPT
    DOMINION MINERALS LIMITED
    $DLM
    PARADIGM BIOPHARMACEUTICALS LIMITED..
    $PAR
    ECOFIBRE LIMITED
    $EOF
    ALTHEA GROUP HOLDINGS LIMITED
    $AGH

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions